Refractory Epilepsy

Neurology
1
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

SK Life Science
SK Life ScienceNJ - Paramus
1 program
1
RWJ-333369Phase 21 trial
Active Trials
NCT00228969CompletedEst. May 2006
Neuroelectrics
NeuroelectricsSpain - Barcelona
2 programs
Cathodal Transcranial Direct Current StimulationN/A1 trial
STARSTIM deviceN/A1 trial
Active Trials
NCT02866240CompletedEst. Dec 2019
NCT04770337RecruitingEst. Jul 2026
UP
UCB PharmaBelgium - Brussels
1 program
European Non-interventional Study on Refractory Epilepsy With Developmental DelayN/A1 trial
Active Trials
NCT04398667Terminated93Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SK Life ScienceRWJ-333369
NeuroelectricsSTARSTIM device
UCB PharmaEuropean Non-interventional Study on Refractory Epilepsy With Developmental Delay
NeuroelectricsCathodal Transcranial Direct Current Stimulation

Clinical Trials (4)

Total enrollment: 93 patients across 4 trials

NCT00228969SK Life ScienceRWJ-333369

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

Start: Feb 2005Est. completion: May 2006
Phase 2Completed
NCT04770337NeuroelectricsSTARSTIM device

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Start: Oct 2021Est. completion: Jul 2026
N/ARecruiting
NCT04398667UCB PharmaEuropean Non-interventional Study on Refractory Epilepsy With Developmental Delay

European Non-interventional Study on Refractory Epilepsy With Developmental Delay

Start: Mar 2019Est. completion: Sep 202093 patients
N/ATerminated
NCT02866240NeuroelectricsCathodal Transcranial Direct Current Stimulation

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Start: Sep 2017Est. completion: Dec 2019
N/ACompleted

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
8h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
8h ago

Director of Finance

CoMind
London, UK
8h ago

Electronics Engineering Manager

CoMind
London, UK
8h ago

Director of Information Technology

Zavation Medical Products
8h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 93 patients
3 companies competing in this space

Related Indications

Multiple Sclerosis(274)Schizophrenia(255)Epilepsy(242)Parkinson Disease(171)Alzheimer's Disease(165)Parkinson's Disease(160)Alzheimer Disease(117)Stroke(102)Relapsing-Remitting Multiple Sclerosis(83)Depression(82)